Waldenstrom's Macroglobulinemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Expanded Access Program for Pirtobrutinib for Participants With B-Cell Cancer
Conditions: Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Lymphocytic, Small; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Ritcher's Transformation, Syndrome Intervention: Drug: Pirtobrutinib Sponsor: Loxo Oncology, Inc. Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2021 Category: Research Source Type: clinical trials
Efficacy of Venetoclax in Combination With Rituximab in Waldenstr öm's Macroglobulinemia
Condition: Waldenstrom Macroglobulinemia Interventions: Drug: Venetoclax; Rituximab; Drug: DRC Sponsors: University of Ulm; Institute for Medical Informatics, Biometry and Epidemiology, University of Munich; Zentrum für Klinische Studien Ulm; AbbVie; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2021 Category: Research Source Type: clinical trials
